Use of a severe acute respiratory coronavirus virus 2 (SARS-CoV-2) strand-specific assay to evaluate for prolonged viral replication >20 days from illness onset.
Jessica D FergusonRalph TayyarGustavo ContrerasMelanie A KienerAlex N ZimmetCaitlin A ContagGuillermo Rodriguez-NavaLucy S TompkinsJohn ShepardAyelet RosenthalAruna K SubramanianBenjamin A PinskyJorge L SalinasPublished in: Infection control and hospital epidemiology (2023)
Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) real-time reverse-transcription polymerase chain reaction (rRT-PCR) strand-specific assay can be used to identify active SARS-CoV-2 viral replication. We describe the characteristics of 337 hospitalized patients with at least 1 minus-strand SARS-CoV-2 assay performed >20 days after illness onset. This test is a novel tool to identify high-risk hospitalized patients with prolonged SARS-CoV-2 replication.